Filing Details
- Accession Number:
- 0001140361-16-064404
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-10 19:06:17
- Reporting Period:
- 2016-04-29
- Filing Date:
- 2016-05-10
- Accepted Time:
- 2016-05-10 19:06:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380710 | Eric George Davis | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-29 | 414 | $51.26 | 91,894 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2016-05-06 | 1,696 | $80.80 | 90,198 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-05-09 | 10,000 | $84.55 | 80,198 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-10 | 4,658 | $86.32 | 75,540 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015, to April 30, 2016.
- The price in column 4 is the weighted average. The price actually ranged from $84.50 to $84.72. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.
- The price in column 4 is the weighted average. The price actually ranged from $86.3140 to $86.3210. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
